Fluorimetric Intensity Measurement of BRCA-Associated Mutations in Plasma
This test measures the presence of genetic mutations linked to an increased risk of breast and ovarian cancer in a blood sample. It helps determine if you may benefit from additional screening or preventive measures.
["This test assesses your genetic risk for certain cancers by detecting specific mutations in your DNA."]
Key facts at a glance
- LOINC
- 85310-1
- Short code
- ER fluor intensity Br ca spec Ql ImStn
- Synonyms
- ER fluor intensity Br ca spec Ql ImStn
- Category
- coagulation
- Sample
- serum
- Container
- Red-top tube (SST)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- immune-stain
- CPT
- 86430
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
Why This Test Might Be Ordered
Your healthcare provider may recommend this test if you have a family history of breast or ovarian cancer, or if you are at high risk due to other factors like age or specific genetic syndromes. It’s also used in certain screening programs for people with a personal or family history of these cancers.
What to Expect Before the Test
No special preparation is needed for this blood test. You may have a small needle inserted into your arm to draw a blood sample, similar to other routine blood tests. The process usually takes a few minutes.
What Happens During the Test
The blood sample is analyzed using a specialized technique that detects mutations in the BRCA genes. This involves examining the DNA for specific changes that may increase cancer risk. The results are compared to known genetic profiles to identify mutations.
What the Results Mean
Results can be categorized as negative (no mutations detected), positive (mutations found), or uncertain. A positive result means you may have a higher risk of breast or ovarian cancer and may need further testing or monitoring. A negative result suggests no mutations were found in this test.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
This test is critical for identifying individuals at higher risk for hereditary breast and ovarian cancer. Early detection allows for proactive management, such as increased surveillance, risk-reducing surgeries, or chemoprevention strategies. It helps guide personalized cancer prevention plans tailored to your genetic profile.
Short name
BRCA Mutation Screening (Fluorimetric)
Frequently asked questions
What does a positive result mean for my health?
Will this test affect my insurance coverage or future medical care?
Can I get this test if I don’t have a family history of cancer?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy